Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 20, 2018 05:51 ET | Source: H. Lundbeck A/S

Lundbeck increases its share capital by 6,574 shares (0.0033 % of outstanding shares) as a result of exercise of employee warrants

Valby, Nov. 20, 2018 (GLOBE NEWSWIRE) -- - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 32,870 as a consequence of the exercise of employee...
November 07, 2018 01:42 ET | Source: H. Lundbeck A/S

Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 raised

Valby, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Financial report for the period 1 January to 30 September 2018 Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in...
October 25, 2018 10:34 ET | Source: H. Lundbeck A/S

Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia

Valby, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Corporate Release Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant...
October 25, 2018 10:34 ET | Source: H. Lundbeck A/S

Lundbeck opdaterer om klinisk fase III studie af Lu AF35700 til behandlingsresistent skizofreni

Valby, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Selskabsmeddelse Lundbeck opdaterer om klinisk fase III studie af Lu AF35700 til behandlings-resistent...
September 28, 2018 03:30 ET | Source: H. Lundbeck A/S

Takeda and Lundbeck submit New Drug Application (NDA) for vortioxetine in Japan for the treatment of Major Depressive Disorder (MDD)

Copenhagen, Sept. 28, 2018 (GLOBE NEWSWIRE) -- NDA submission highlights four key studies involving approximately 1,400 patients, including the pivotal phase III study conducted in JapanPivotal...
September 28, 2018 03:30 ET | Source: H. Lundbeck A/S

Takeda og Lundbeck indsender registreringsansøgning (NDA) for vortioxetin i Japan til behandling af depression

Copenhagen, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Registreringsansøgningen fremhæver fire nøglestudier, der omfatter cirka 1.400 patienter, herunder det pivotale fase III-studie udført i JapanDet...
August 08, 2018 01:09 ET | Source: H. Lundbeck A/S

Lundbeck realized 14% growth in revenue (local currencies) and 83% growth in EPS

Valby, Aug. 08, 2018 (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 9,288 million in the first six months of 2018 representing an increase of 9% (14% in local currencies) compared...
July 02, 2018 03:17 ET | Source: H. Lundbeck A/S

Dr. Deborah Dunsire bliver ny administrerende direktør for Lundbeck

Valby, Denmark, 2. juli 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, at bestyrelsen har udnævnt Dr. Deborah Dunsire som ny administrerende direktør for Lundbeck. Dr. Deborah Dunsire...
July 02, 2018 03:17 ET | Source: H. Lundbeck A/S

Dr. Deborah Dunsire named new President and CEO of Lundbeck

Valby, Denmark, 2 July 2018 - H. Lundbeck A/S (Lundbeck) today announced that the Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Dr. Dunsire...
July 02, 2018 02:41 ET | Source: H. Lundbeck A/S

Dr. Deborah Dunsire bliver ny administrerende direktør for Lundbeck

Valby, Denmark, 2. juli 2018 - H. Lundbeck A/S (Lundbeck) har i dag offentliggjort, at bestyrelsen har udnævnt Dr. Deborah Dunsire som ny administrerende direktør for Lundbeck. Dr. Deborah Dunsire...